Guests: Carolyn Ringel, JD, MBEConsultant and Instructor for Harvard Medical School Center for BioethicsLinkedIn: https://www.linkedin.com/in/carolyn-baker-ringel-35378431/ David Barzilai, MD, PhD, MBA, MS, DipABLMFounder and CEO of Barzilai Longevity ConsultingLinkedIn: https://www.linkedin.com/in/agingdoc/Website: https://www.barzilaiconsulting.com/david ________________ Longevity ethics? What if extending healthspan required rethinking not just medicine, but society itself? Phil Newman and Dr. Nina Patrick sit down with Carolyn Ringel, a bioethicist at Harvard Medical School, and Dr. David Barzilai, a longevity medicine physician. They explore how aging research and geroscience can address urgent health issues like heart disease, diabetes, cancer, and dementia, while highlighting the ethical responsibilities of science and medicine. Carolyn emphasizes that studying aging is not an either-or with addressing current health crises; by understanding aging, we can better prevent and treat age-related diseases. She also explores how healthcare funding, housing, and social infrastructure can be designed to support longer, healthier lives, creating a society where longevity benefits everyone. David explains the importance of trusted patient-doctor relationships, scientific literacy, and emerging interventions like aging biomarkers, cellular reprogramming, and regenerative medicine. He highlights the potential of integrated, systems-based approaches and AI-driven research to accelerate the development of safe, effective longevity strategies. This conversation highlights that longevity is not just about supplements, exercise, or clinical interventions. Ethical frameworks, societal design, and evidence-based medicine all play a crucial role in extending healthspan and improving quality of life. In this episode, you’ll learn: How geroscience can prevent multiple age-related diseases simultaneouslyThe ethical considerations of patient empowerment and longevity interventionsHow societal infrastructure and healthcare funding can support longer, healthier livesThe role of biomarkers and AI in safe, effective longevity strategiesThe future of integrated, evidence-based, and ethical longevity care If you care about protecting your long-term health and want to understand how ethics, policy, and science intersect to shape the future of healthspan, this is a conversation you don’t want to miss. Subscribe for weekly episodes that explore longevity science, healthspan optimization, and the emerging technologies, policies, and strategies ________________ Connect with our hosts: Phil Newman: https://qrco.de/bgXpNY Dr. Nina Patrick: https://qrco.de/bgXpKn
